Opportunity Information: Apply for 7200AA22APS00002

The Promoting Results and Outcomes through Policy and Economic Levers (PROPEL) opportunity is a USAID Office of Population and Reproductive Health (PRH) Annual Program Statement (APS) designed to strengthen the broader "enabling environment" that determines whether health programs can actually perform and last. Rather than focusing only on delivering services in clinics, this APS targets the policy, financing, governance, and accountability conditions that shape how equitable and sustainable health services, supplies, and delivery systems operate over time. The overall aim is to help countries build systems that can reliably fund, manage, and improve health services in ways that are fair, transparent, and responsive to public needs.

A central theme of PROPEL is improving health systems through policy development and implementation, along with creating financing arrangements that are adequate, predictable, and sustainable. In practice, this points to work such as supporting governments to craft or reform health and reproductive health policies, strengthening implementation rules and procedures, and helping public systems move away from short-term or donor-dependent funding toward more stable domestic resource commitments. The APS also highlights the importance of stronger government stewardship, transparency, and accountability, indicating support for reforms that improve oversight, reduce bottlenecks and leakage, and make decision-making more evidence-based and open to scrutiny. Alongside government-facing work, PROPEL explicitly calls for an engaged and informed civil society that is prepared to advocate for better systems and outcomes, signaling that community groups, watchdog organizations, and advocacy partners may play a meaningful role in pushing for policy follow-through and improved performance.

Programmatically, PROPEL places specific emphasis on voluntary, rights-based family planning and reproductive health (FP/RH). That language matters because it signals that activities should protect informed choice, voluntarism, non-discrimination, and quality of care, and that results are not meant to be pursued through coercive or target-driven approaches. The APS also prioritizes integration of FP/RH with maternal and child health (MCH) and HIV/AIDS efforts, reflecting USAID's interest in more coordinated approaches that reduce fragmentation and reach clients more effectively across services. More broadly, PROPEL is intended to work across health systems and other development sectors, which suggests that interventions may involve actors and levers outside the health ministry alone, including finance ministries, social protection systems, insurance schemes, public financial management institutions, and other cross-sector policy platforms that influence health outcomes.

In terms of intended results, the APS frames success as improvements in FP/RH demand and uptake and, ultimately, better health outcomes. The logic is that when policies are clearer and better implemented, financing is more dependable, governance is stronger, and civil society can hold systems accountable, then services and commodities are more consistently available and higher quality, trust increases, and people are more likely to seek and continue using FP/RH services by choice. The health outcome focus implies attention not only to service coverage but also to system performance and sustainability, including whether reforms persist beyond the life of a single project.

From a funding and administrative standpoint, PROPEL is a discretionary opportunity from the U.S. Agency for International Development, using a cooperative agreement as the funding instrument. A cooperative agreement typically means substantial involvement by the government during implementation compared with a standard grant, such as collaboration on work planning, technical direction, or coordination with other USAID efforts. The opportunity is identified as Funding Opportunity Number 7200AA22APS00002 and is categorized under the Health activity area, with CFDA number 98.001. The opportunity was created on 2021-12-07 and lists an original closing date of 2027-11-30, which is consistent with an APS structure that may have multiple rounds and allow concept paper submissions over an extended period.

Eligibility is broad: U.S. and non-U.S. organizations may apply, including public and private entities, for-profit and nonprofit organizations, institutions of higher education, public international organizations, and non-governmental organizations. Applicants are expected to submit a concept paper under each round of the APS, meaning the process is likely staged, with concept papers used to screen and shape potential awards before more detailed applications are invited. The listed award ceiling is $180,000,000, indicating the program can support large-scale awards depending on USAID's determinations, priorities, and available funding. The number of expected awards is not specified in the provided data, which usually means the agency may make multiple awards over time depending on the quality of submissions and evolving program needs.

  • The Agency for International Development in the health sector is offering a public funding opportunity titled "Promoting Results and Outcomes through Policy and Economic Levers (PROPEL)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 98.001.
  • This funding opportunity was created on 2021-12-07.
  • Applicants must submit their applications by 2027-11-30.
  • Each selected applicant is eligible to receive up to $180,000,000.00 in funding.
  • Eligible applicants include: Others.
Apply for 7200AA22APS00002

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: Agency for International Development

Browse more opportunities from the same category: Health

Next opportunity: Ocular Surface Innervation from Cell Types to Circuit Functions (U01 Clinical Trial Not Allowed)

Previous opportunity: Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimers Disease and Related Dementias (R01 Clinical Trial Not Allowed)

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for 7200AA22APS00002

 

Applicants also applied for:

Applicants who have applied for this opportunity (7200AA22APS00002) also looked into and applied for these:

Funding Opportunity
Ocular Surface Innervation from Cell Types to Circuit Functions (U01 Clinical Trial Not Allowed) Apply for RFA EY 21 004

Funding Number: RFA EY 21 004
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional) Apply for RFA EB 21 001

Funding Number: RFA EB 21 001
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Research Centers in Minority Institutions (RCMI) (U54 Clinical Trials Optional) Apply for RFA MD 22 002

Funding Number: RFA MD 22 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed) Apply for RFA RM 22 007

Funding Number: RFA RM 22 007
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
USAID/Uganda Health Activity Apply for RFI 720617 22 002

Funding Number: RFI 720617 22 002
Agency: Uganda USAID-Kampala
Category: Health
Funding Amount: Case Dependent
NIH-DOD-VA Pain Management Collaboratory Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required) Apply for RFA AT 22 006

Funding Number: RFA AT 22 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
SPARC VNS Endpoints from Standardized Parameters (VESPA) (U54 Clinical Trial Required) Apply for RFA RM 22 002

Funding Number: RFA RM 22 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
PROPEL Health: Promoting Results and Outcomes through Policy and Economic Leavers Apply for 7200AA22APS00002 01

Funding Number: 7200AA22APS00002 01
Agency: Agency for International Development
Category: Health
Funding Amount: $100,000,000
Center for Rapid Surveillance of Tobacco (CRST) to Assess Changes in Use Behaviors, Product Marketing, and the Marketplace (U01 Clinical Trial Not Allowed) Apply for RFA OD 22 002

Funding Number: RFA OD 22 002
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Resources to Promote Coordination and Collaboration across Deeply Phenotyped Longitudinal Behavioral and Social Studies of Aging (U24 Clinical Trial Not Allowed) Apply for RFA AG 23 003

Funding Number: RFA AG 23 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
NIA Renewal and Revision Cooperative Agreements in AD/ADRD Research (U54 Clinical Trial Optional) Apply for PAR 22 077

Funding Number: PAR 22 077
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) Apply for PAR 22 093

Funding Number: PAR 22 093
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional) Apply for PAR 22 094

Funding Number: PAR 22 094
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional) Apply for RFA MH 22 135

Funding Number: RFA MH 22 135
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional) Apply for RFA MH 22 136

Funding Number: RFA MH 22 136
Agency: National Institutes of Health
Category: Health
Funding Amount: $275,000
Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional) Apply for RFA AI 21 079

Funding Number: RFA AI 21 079
Agency: National Institutes of Health
Category: Health
Funding Amount: $900,000
Lipids in Brain Aging and Alzheimer's Disease (AD) and its Related Dementias (ADRD) (R01 Clinical Trial Not Allowed) Apply for RFA AG 23 009

Funding Number: RFA AG 23 009
Agency: National Institutes of Health
Category: Health
Funding Amount: $500,000
Biomedical Research Facilities (C06 Clinical Trial Not Allowed) Apply for PAR 22 088

Funding Number: PAR 22 088
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Limited Competition: Development and Renovation of Housing, Breeding, and Research Spaces for Existing NIH-supported NHP Colonies (C06 Clinical Trial Not Allowed) Apply for PAR 21 363

Funding Number: PAR 21 363
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) Apply for RFA MD 22 003

Funding Number: RFA MD 22 003
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "7200AA22APS00002", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: